Screen for prior viral infections in Guillain-Barre Syndrome (GBS)

Screening for antecedent viral infections in Guillain-Barre Syndrome (GBS)

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Observational

Source

CTRI

Registry ID

CTRI/2023/04/051666

Enrollment

Registered

2023-04-17

Start date

Unknown

Completion date

Unknown

Last updated

2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G610- Guillain-Barre syndrome Health Condition 2: G968- Other specified disorders of central nervous system

Interventions

Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: Blood and CSF samples from patients meeting the diagnostic criteria for GBS before initiation of the treatment

Exclusion criteria

Exclusion criteria: Blood and CSF samples from patients who received treatment with intravenous immunoglobulin and/or have undergone plasmapheresis

Design outcomes

Primary

Measure	Time frame
Prevalence of antecedent viral infection in GBS patient and control will b determined. Determine the association of different antecedent viral infections in GBS. Timepoint: 9 months	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactMs Sreelakshmi V

Manipal Institute of Virology

amrita.pattanaik@manipal.edu

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026